PubRank

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.

PubWeight™: 2.81‹?› | Rank: Top 1%

🔗 View Article (PMID 25085960)

Published in Circulation on August 01, 2014

Authors

David J Cohen1, Ruben L Osnabrugge2, Elizabeth A Magnuson2, Kaijun Wang2, Haiyan Li2, Khaja Chinnakondepalli2, Duane Pinto2, Mouin S Abdallah2, Katherine A Vilain2, Marie-Claude Morice2, Keith D Dawkins2, A Pieter Kappetein2, Friedrich W Mohr2, Patrick W Serruys2, SYNTAX Trial Investigators

Author Affiliations

1: From Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City (D.J.C., R.L.O., E.A.M., K.W., H.L., K.C.); Erasmus University Medical Center, Rotterdam, The Netherlands (R.L.O., A.P.K., P.W.S.); Harvard School of Public Health, Boston, MA (D.P.); Institut Jacques Cartier, Massy, France (M.-C.M.); Boston Scientific, Natick, MA (K.D.D.); and Herzzentrum Universität Leipzig, Leipzig, Germany (F.W.M.). dcohen@saint-lukes.org.
2: From Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City (D.J.C., R.L.O., E.A.M., K.W., H.L., K.C.); Erasmus University Medical Center, Rotterdam, The Netherlands (R.L.O., A.P.K., P.W.S.); Harvard School of Public Health, Boston, MA (D.P.); Institut Jacques Cartier, Massy, France (M.-C.M.); Boston Scientific, Natick, MA (K.D.D.); and Herzzentrum Universität Leipzig, Leipzig, Germany (F.W.M.).

Associated clinical trials:

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX) | NCT00114972

Articles citing this ↘

Focused Cardiac Ultrasound in Place of Repeat Echocardiography: Reliability and Cost Implications. J Am Soc Echocardiogr (2015) 1.45

Evaluating the Cost-effectiveness of Catheter Ablation of Atrial Fibrillation. Arrhythm Electrophysiol Rev (2014) 0.76

Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction. Hawaii J Med Public Health (2016) 0.75

The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis. Ann Thorac Surg (2015) 0.75

Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial". Circulation (2015) 0.75

Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease. Evid Based Med (2015) 0.75

Coronary artery disease: Cost-effectiveness of CABG surgery versus PCI in complex CAD. Nat Rev Cardiol (2014) 0.75

Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge-Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? JACC Cardiovasc Interv (2015) 0.75

Articles by these authors ⇆

Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. J Am Coll Cardiol (2017) 0.75